Binding of " AT4 receptor" ligands to insulin regulated aminopeptidase (IRAP) in intact Chinese hamster ovary cells

Molecular and Cellular Endocrinology

Volumn 339, Issue 1-2, 2011, Pages 34-44

  Demaegdt, Heidi ^a   Gard, Paul ^b   De Backer, Jean Paul ^a   Lukaszuk, Aneta ^a   Szemenyei, Erzsébet ^c   Tóth, Géza ^c   Tourwé, Dirk ^a   Vauquelin, Georges ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

AL 11; Ang IV; CHO cells; Internalization; IRAP; Radioligand binding

Indexed keywords

AL 11; AMINOPEPTIDASE; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN II [3-8] RECEPTOR; ANGIOTENSIN RECEPTOR; INSULIN REGULATED AMINOPEPTIDASE; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN HEK293; CELL SURFACE; CHO CELL; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; INTERNALIZATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOTENSIN II; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CRICETULUS; CYSTINYL AMINOPEPTIDASE; HEK293 CELLS; HEMOGLOBINS; HUMANS; LIGANDS; PEPTIDE FRAGMENTS; PEPTIDOMIMETICS; PROTEIN BINDING; PROTEIN TRANSPORT; RADIOLIGAND ASSAY;

EID: 79958025200     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.03.005     Document Type: Article

References (70)

1. Albiston A.L., McDowall S.G., Matsacos D., Sim P., Clune E., Mustafa T., Lee J., Mendelsohn F.A., Simpson R.J., Connolly L.M., Chai S.Y. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 2001, 276:48623-48626.
2. Axén A., Lindeberg G., Demaegdt H., Vauquelin G., Karlén A., Hallberg M. Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands. J. Pept. Sci. 2006, 12:705-713.
3. Chai S.Y., Fernando R., Peck G., Ye S.Y., Mendelsohn F.A., Jenkins T.A., Albiston A.L. The angiotensin IV/AT4 receptor. Cell. Mol. Life Sci. 2004, 61:2728-2737.
4. Charlton S., Vauquelin G. Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays. Br. J. Pharmacol. 2010, 161:1250-1265.
5. Chen H., Roques B.P., Fournié-Zaluski M.C. Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor. Bioorg. Med. Chem. Lett. 1999, 9:1511-1516.
6. Cheng Y., Prusoff W.H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22:3099-3108.
7. Coombs D., Goldstein B. Effects of geometry of the immunological synapse on the delivery of effector molecules. Biophys. J. 2004, 87:2215-2220.
8. Demaegdt H., Vanderheyden P.M.L., De Backer J.P., Mosselmans S., Laeremans H., Le M.T., Kersemans V., Michotte Y., Vauquelin G. Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity. Biochem. Pharmacol. 2004, 68:885-892.
9. Demaegdt H., Laeremans H., De Backer J.P., Mosselmans S., Le M.T., Kersemans V., Michotte Y., Vauquelin G., Vanderheyden P. Synergistic modulation of cystinyl aminopeptidase by divalent cation chelators. Biochem. Pharmacol. 2004, 68:893-900.
10. Demaegdt H., Lenaerts P.J., Swales J., De Backer J.P., Laeremans H., Le M.T., Kersemans K., Vogel L., Michotte Y., Vanderheyden P., Vauquelin G. AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Ang IV only binds to the cystinyl aminopeptidase apoenzyme. Eur. J. Pharmacol. 2006, 546:19-27.
11. Demaegdt H., Smitz L., De Backer J.P., Le M.T., Bauwens M., Szemenyei E., Tóth G., Michotte Y., Vanderheyden P., Vauquelin G. Translocation of the insulin-regulated aminopeptidase to the cell surface: detection by radioligand binding. Br. J. Pharmacol. 2008, 154:872-881.
12. Demaegdt H., Lukaszuk A., De Buyser E., De Backer J.P., Szemenyei E., Tóth G., Chakravarthy S., Panicker P., Michotte Y., Tourwé D., Vauquelin G. Selective labeling of IRAP by the tritiated AT4 receptor ligands [3H]Angiotensin IV and its stable analog [3H]AL-11. Mol. Cell. Endocrinol. 2009, 311:77-86.
13. Demaegdt, H., De Backer, J.P., Lukaszuk, A., Tóth, G., Szemenyei, E., Tourwé, D., Vauquelin, G. Angiotensin IV only displays low affinity for native insulin-regulated amonipeptidase (IRAP). Fund. Clin. Pharmacol., in press.
14. Fernando R.N., Albiston A.L., Chai S.Y. The insulin-regulated aminopeptidase IRAP is colocalised with GLUT4 in the mouse hippocampus-potential role in modulation of glucose uptake in neurones?. Eur. J. Neurosci. 2008, 28:588-598.
15. Fierens F.L.P., Vanderheyden P.M.L., De Backer J.-P., Vauquelin G. Binding of the antagonist [3H]candesartan to angiotensin II AT1 receptor-transfected Chinese hamster ovary cells. Eur. J. Pharmacol. 1999, 367:413-422.
16. Garreau I., Chansel D., Vandermeersch S., Fruitier I., Piot J.M., Ardaillou R. Hemorphins inhibit angiotensin IV binding and interact with aminopeptidase N. Peptides 1998, 19:1339-1348.
17. Garza L.A., Birnbaum M.J. Insulin-responsive aminopeptidase trafficking in 3T3-L1 adipocytes. J. Biol. Chem. 2000, 275:2560-2567.
18. Gifford A.N., Gatley J., Volkow N.D. Evaluation of the importance of rebinding to receptors in slowing the approach to equilibrium of high-affinity PET and SPECT radiotracers. Synapse 1998, 28:167-175.
19. Hosaka T., Brooks C.C., Presman E., Kim S.K., Zhang Z., Breen M., Gross D.N., Sztul E., Pilch P.F. p115 interacts with the GLUT4 vesicle protein IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation. Mol. Biol. Cell 2005, 16:2882-2890.
20. Johna H., Schulza S., Forssmann W.-G. Comparative In Vitro degradation of the human hemorphin LVV-H7 in mammalian plasma analysed by capillary zone electrophoresis and mass spectrometry. Biopharm. Drug Dispos. 2007, 28:73-85.
21. Johnson A.O., Subtil A., Petrush R., Kobylarz K., Keller S.R., McGraw T.E. Identification of an insulin-responsive, slow endocytic recycling mechanism in Chinese hamster ovary cells. J. Biol. Chem. 1998, 273:17968-17977.
22. Johnson A.O., Lampson M.A., McGraw T.E. A di-leucine sequence and a cluster of acidic amino acids are required for dynamic retention in the endosomal recycling compartment of fibroblasts. Mol. Biol. Cell 2001, 12:367-381.
23. Kandror K.V., Pilch P.F. gp160, a tissue-specific marker for insulin-activated glucose transport. Proc. Natl. Acad. Sci. U.S.A. 1994, 8017-8021.
24. Katagiri H., Asano T., Yamada T., Aoyama T., Fukushima Y., Kikuchi M., Kodama T., Oka Y. Acyl-coenzyme A dehydrogenases are localized on GLUT4-containing vesicles via association with insulin-regulated aminopeptidase in a mannerk dependent on its dileucine motif. Mol. Endocrinol. 2002, 16:1049-1059.
25. Keller S.R., Scott H.M., Mastick C.C., Aebersold R., Lienhard G.E. Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles. J. Biol. Chem. 1995, 270:23612-23618.
26. Koenig J.A., Edwardson J.M. Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol. Sci. 1997, 18:276-287.
27. Koenig J.A., Kaur R., Dodgeon I., Edwardson M., Humphrey P.A. Fates of endocytosed somatostatin sst2 receptors and associated agonists. Biochem. J. 1998, 336:291-298.
28. Lampson M.A., Racz A., Cushman S.W., McGraw T.E. Demonstration of insulin-responsive trafficking of GLUT4 and vpTR in fibroblasts. J. Cell Sci. 2000, 113:4065-4076.
29. Larance M., Ramm G., Stockli J., van Dam E.M., Winata S., Wasinger V., Simpson F., Graham M., Junutula J.R., Guilhaus M., James D.E. Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J. Biol. Chem. 2005, 280:37803-37813.
30. Le M.T., Vanderheyden P.M.L., Szaszák M., Hunyady L., Vauquelin G. Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N- and C-terminal amino acid residues of angiotensin II in human AT1 receptor activation. J. Biol. Chem. 2002, 277:23107-23110.
31. Le M.T., De Backer J.P., Hunyady L., Vanderheyden P.M., Vauquelin G. Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells. Eur. J. Pharmacol. 2005, 513:35-45.
32. Lee J., Mustafa T., McDowall S.G., Mendelsohn F.A., Brennan M., Lew R.A., Albiston A.L., Chai S.Y. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase. J. Pharmacol. Exp. Ther. 2003, 305:205-211.
33. Leff P., Martin G.R. Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists?. Br. J. Pharmacol. 1986, 88:585-593.
34. Lew R.A., Mustafa T., Ye S., McDowall S.G., Chai S.Y., Albiston A.L. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J. Neurochem. 2003, 86:344-350.
35. Lim S.N., Bonzelius F., Low S.H., Wille H., Weimbs T., Herman G.A. Identification of discrete classes of endosome-derived small vesicles as a major cellular pool for recycling membrane proteins. Mol. Biol. Cell 2001, 12:981-995.
36. Lukaszuk A., Demaegdt H., Szemenyei E., Tóth G., Tymecka D., Misicka A., Karoyan V., Vanderheyden P., Vauquelin G., Tourwé D. β-Homo-amino acid scan of Angiotensin IV. J. Med. Chem. 2008, 51:2291-2296.
37. Lukaszuk A., Demaegdt H., Feytens D., Vanderheyden P., Vauquelin G., Tourwé D. The replacement of His(4) in Angiotensin IV by conformationally constrained residues provides highly potent and selective analogs. J. Med. Chem. 2009, 52:5612-5618.
38. Luttrell L.M., Lefkowitz R.J. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 2002, 115:455-465.
39. Malany S., Hernandez L.M., Smith W.F., Crowe P.D., Hoare S.R.J. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors. J. Recept. Signal Transduct. Res. 2009, 29:84-93.
40. Mastick C.C., Aebersold R., Lienhard G.E. Characterization of a major protein in GLUT4 vesicles. Concentration in the vesicles and insulin-stimulated translocation to the plasma membrane. J. Biol. Chem. 1994, 269:6089-6092.
41. Matsumoto H., Nagasaka T., Hattori A., Rogi T., Tsuruoka N., Mizutani S., Tsujimoto M. Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides. Eur. J. Biochem. 2001, 268:3259-3266.
42. Mellman I. Endocytosis and molecular sorting. Annu. Rev. Cell Biol. 1996, 12:575-625.
43. Nakamura H., Itakuara A., Okamura M., Ito M., Iwase A., Nakanishi Y., Okada M., Nagasaka T., Mizutani S. Oxytocin stimulates the translocation of oxytocinase of human vascular endothelial cells via activation of oxytocin receptors. Endocrinology 2000, 141:4481-4485.
44. Packeu A., Wennerberg M., Ballendran A., Vauquelin G. Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a " two-step" competition binding approach. Br. J. Pharmacol. 2010, 161:1311-1328.
45. Packeu A., De Backer J.P., Vauquelin G. Non-competitive interaction between raclopride and spiperone on human D2L-receptors in intact recombinant Chinese hamster ovary cells. Fund. Clin. Pharmacol. 2010, 24:283-291.
46. Peck G.R., Ye S., Pham V., Fernando R.N., Macaulay S.L., Chai S.Y., Albiston A.L. Interaction of the Akt substrate AS160, with the glucose transporter 4 vesicle marker protein, insulin-regulated aminopeptidase. Mol. Endocrinol. 2006, 20:2576-2583.
47. Perry D.C., Mullis K.B., Øie S., Sadée W. Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model. Brain Res. 1980, 199:49-61.
48. Ross S.A., Scott H.M., Morris N.J., Leung W.Y., Mao F., Lienhard G.E., Keller S.R. Characterization of the insulin-regulated membrane aminopeptidase in 3T3-L1 adipocytes. J. Biol. Chem. 1996, 271:3328-3332.
49. Rückert P., Bates S.R., Fisher A.B. Role of clathrin- and actin-dependent endocytotic pathways in lung phospholipid uptake. Am. J. Physiol.: Lung Cell. Mol. Physiol. 2003, 284:L981-L989.
50. Sadée W., Perry D.C., Rosenbaum J.S., Herz A. [3H]-Diprenorphine receptor binding in vivo and in vitro. Eur. J. Pharmacol. 1982, 81:431-440.
51. Sanderson Nydahl K., Pierson J., Nyberg F., Caprioli R.M., Andren P.E. In vivo processing of LVV-hemorphin-7 in rat brain and blood utilizing microdialysis combined with electrospray mass spectrometry. Rapid Commun. Mass Spectrom. 2003, 17:838-844.
52. Spivak C.E., Oz M., Beglan C.L., Shrager R.I. Diffusion delays and unstirred layer effects at monolayer cultures of Chinese hamster ovary cells: radioligand binding, confocal microscopy, and mathematical simulations. Cell Biochem. Biophys. 2006, 45:43-58.
53. Stragier B., Demaegdt H., De Bundel D., Smolders I., Sarre S., Vauquelin G., Ebinger G., Michotte Y., Vanderheyden P. Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat. Brain Res. 2007, 1131:97-105.
54. Stragier B., De Bundel D., Sarre S., Smolders I., Vauquelin G., Dupont A., Michotte Y., Vanderheyden P. Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review. Heart Fail. Rev. 2008, 13:321-337.
55. Subtil A., Lampson M.A., Keller S.R., McGraw T.E. Characterization of the insulin-regulated endocytic recycling mechanism in 3T3-L1 adipocytes using a novel reporter molecule. J. Biol. Chem. 2000, 275:4787-4795.
56. Tojo H., Kaieda I., Hattori H., Katayama N., Yoshimura K., Kakimoto S., Fujisawa Y., Presman E., Brooks C.C., Pilch P.F. The Formin family protein, formin homolog overexpressed in spleen, interacts with the insulin-responsive aminopeptidase and profilin IIa. Mol. Endocrinol. 2003, 17:1216-1229.
57. Tóth G., Lovas S., Ötvös F. Tritium labelling of neuropeptides. Methods in Molecular Biology, Neuropeptide Protocols 1997, 219-230. Humana Press, New Jersey. G.B. Irvine, C.H. Williams (Eds.).
58. Vanderheyden P.M.L., Fierens F.L.P., De Backer J.-P., Fraeyman N., Vauquelin G. Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors. Br. J. Pharmacol. 1999, 126:1057-1065.
59. Vanderheyden P.M.L., De Backer J.P., Demaegdt H., Matziari M., Vauquelin G., Yiotakis A. Metabolism of AT4 receptor binding peptides in the presence of cell membranes of Chinese hamster ovary cells. FEBS J. 2008, 275:322.
60. Vauquelin G., Michotte Y., Smolders I., Sarre S., Ebinger G., Dupont A., Vanderheyden P. Cellular targets for angiotensin II fragments: pharmacological and molecular evidence. JRAAS 2002, 3:195-204.
61. Vauquelin G., Van Liefde I., Vanderheyden P. Models and methods for studying insurmountable antagonism. Trends Pharmacol. Sci. 2002, 23:514-518.
62. Vauquelin G., Szczuka A. Kinetic versus allosteric mechanisms to explain insurmountable antagonism and delayed ligand dissociation. Neurochem. Int. 2007, 51:254-260.
63. Vauquelin G., Charlton S. Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action. Br. J. Pharmacol. 2010, 161:488-508.
64. Vauquelin G. Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time. Expert Opin. Drug Discov. 2010, 5:927-941.
65. Visser C.C., Stevanovic S., Heleen Voorwinden L., Gaillard P.J., Crommelin D.J., Danhof M., De Boer A.G. Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro. J. Drug Target. 2004, 12:145-150.
66. Waters S.B., D'Auria M., Martin S.S., Nguyen C., Kozma L.M., Luskey K.L. The amino terminus of insulin-responsive aminopeptidase causes Glut4 translocation in 3T3-L1 adipocytes. J. Biol. Chem. 1997, 272:23323-23327.
67. Wennerberg M., Cheng L., Hjorth S., Clapham J.C., Ballendran A., Vauquelin G. Binding properties of antagonists to CB1 cannabinoid receptors in intact cells. Fund. Clin. Pharmacol. 2010, 25:200-210.
68. Wright J.W., Krebs L.T., Stobb J.W., Harding J.W. The angiotensin IV system: functional implications. Front. Neuroendocrinol. 1995, 16:23-52.
69. Wright J.W., Yamamoto B.J., Harding J.W. Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets. Prog. Neurobiol. 2008, 84:157-181.
70. Yeh T.Y.J., Sbodio J.I., Tsun Z.Y., Luo B., Chi N.W. Insulin-stimulated exocytosis of GLUT4 is enhanced by IRAP and its partner tankyrase. Biochem. J. 2007, 402:279-290.